Xe-Chun Xia (Hechun Xia, He-Chun Xia)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Transforming Growth Factor

High Fat Diet Induced

Cell Proliferation

Papillary Thyroid

Top Venues

Cancer gene therapy

Journal of materials chemistry. B

This page only lists publications with an associated author ORCID identifier.

Publications

Jian Yao, Jian-Wen Hui, Yan-Jun Chen, Dong-Yang Luo, Jiang-Shu Yan, Yi-Fan Zhang, Yuan-Xiang Lan, Xiu-Rui Yan, Zhi-Hua Wang, Heng Fan, Xe-Chun Xia
Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c. Cancer gene therapy (2023)
Jian Yao, Jian-Wen Hui, Yan-Jun Chen, Dong-Yang Luo, Jiang-Shu Yan, Yi-Fan Zhang, Yuan-Xiang Lan, Xiu-Rui Yan, Zhi-Hua Wang, Heng Fan, Xe-Chun Xia
Correction to: Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c. Cancer gene therapy (2023)
Jian Yao, Jian-Wen Hui, Yan-Jun Chen, Dong-Yang Luo, Jiang-Shu Yan, Yi-Fan Zhang, Yuan-Xiang Lan, Xiu-Rui Yan, Zhi-Hua Wang, Heng Fan, Xe-Chun Xia
Lycium barbarum glycopeptide targets PER2 to inhibit lipogenesis in glioblastoma by downregulating SREBP1c. Cancer gene therapy (2023)
Yifan Zhang, Xvlei Hu, Hailiang Li, Jian Yao, Ping Yang, Yuanxiang Lan, Xe-Chun Xia
Circadian Period 2 (Per2) downregulate inhibitor of differentiation 3 (Id3) expression via PTEN/AKT/Smad5 axis to inhibits glioma cell proliferation. Bioengineered 13 (5) (2022)
Li Hou, Hai-Liang Li, Hai-Yan Wang, Dede Ma, Jing Liu, Liqiong Ma, Zhihua Wang, Zhihua Yang, Fa-Xuan Wang, Xe-Chun Xia
The circadian clock gene PER2 enhances chemotherapeutic efficacy in nasopharyngeal carcinoma when combined with a targeted nanosystem. Journal of materials chemistry. B 8 (24) (2021)